About Teikoku Seiyaku
About
News
-
- 2023.6.29
- President and CEO Misako Fujioka Interviewed in Newsweek International
-
- 2023.3.28
- Change in The Board of Directors
-
- 2023.3.15
- Notice of Launch of ALLYDONE® Patches 27.5 mg / ALLYDONE® Patches 55 mg in Japan as Japan’s First Donepezil Transdermal Therapeutic System
-
- 2022.12.23
- Manufacturing and Marketing Approval Received in Japan for ALLYDONE® Patches for Treatment of Dementia Due to Alzheimer’s Disease as Japan’s First Donepezil Transdermal Therapeutic System
-
- 2022.4.21
- Execution of a license agreement on an exclusive marketing right in Japan of the first donepezil transdermal therapeutic system in Japan
Company
Since our foundation over 170 years ago, Teikoku Seiyaku has used the transdermal technology we have cultivated to respond to and anticipate the needs of both patients and medical professionals.
View More